26 / 68
206
te pulmonar en niños. Arch Bronconeumol 2013; 49:
523-8.
3.- Maurer J R, Frost A E, Estenne M, Higen-
bottam T, Glanville A R. International guideli-
nes for the selection of lung transplant candidates. The
International Society for Heart and Lung Transplan-
tation, the American Thoracic Society, the American
Society of Transplant Physicians, the European Respira-
tory Society. J Heart Lung Transplant 1998; 17 : 703-9.
4.- Orens J B, Estenne M, Arcasoy S, Conte J
V, Corris P, Egan J J, et al; Pulmonary Scientific
Council of the International Society for Heart and
Lung Transplantation. International guidelines for the
selection of lung transplant candidates: 2006 update-a
consensus report from the Pulmonary Scientific Council
of the International Society for Heart and Lung Trans-
plantation. J Heart Lung Transplant 2006; 25: 745-55.
5.- Estenne M, Maurer J R, Boehler A, Egan J
J, Frost A, Hertz M, et al. Bronchiolitis obliterans
syndrome 2001: an update of the diagnostic criteria. J
Heart Lung Transplant 2002; 21: 297-310.
6.- Liu M, Worley S, Arrigain S, Aurora P,
Ballman M, Boyer D, et al. Respiratory viral in-
fections within one year alter pediatric lung transplant.
Trasplant Infect Dis 2009; 11: 304-12.
7.- KhalifahA P, Hachem R R, ChakinalaM M,
Schechtman K, Patterson A, Schuster D.
Respiratory viral infections are a distinct risk for bron-
chiolitis obliterans syndrome and death. Am J Resp Crit
Care Med 2004; 170: 181-7.
8.- Liu M, Mallory G B, Schecter, Worley S,
Arrigain S, Robertson J, et al. Long-term impact
of respiratory viral infection after pediatric lung trans-
plantation. Pediatr Transplantation 2010; 14: 431-6.
Correspondencia a:
Dr. Joel Melo T.
Clínica Las Condes
Lo Fontecilla 441
Las Condes, Santiago de Chile.
Email:
jmelo@clinicalascondes.clJ. Melo T. et al.
Rev Chil Enferm Respir 2015; 31: 201-206